Postmarket Data Tops FDA’s Research Wish List In Safety Self-Assessment
This article was originally published in The Pink Sheet Daily
Executive Summary
Industry must weigh value of strengthening agency’s armamentarium as FDA continues to seek outside collaborations in follow-up to 2011 publication.